Evidence map›Paper›PMID 25394382›Full record

ArticleMolecular neurobiology2015

Guanosine Protects Against Cortical Focal Ischemia. Involvement of Inflammatory Response.

Gisele Hansel, André Comiran Tonon, Felipe Lhywinskh Guella, Letícia Ferreira Pettenuzzo, Thiago Duarte, Marta Maria Medeiros Frescura Duarte, Jean Pierre Oses, Matilde Achaval, Diogo Onofre Souza

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Constituents fromMolecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Molecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Gisele HanselDepartment of Biochemistry, Postgraduate Program in Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos, 2600 - Anexo, Santa Cecília, 90035-003, Porto Alegre, RS, Brazil. gihansel@gmail.com.
André Comiran TononDepartment of Biochemistry, Postgraduate Program in Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos, 2600 - Anexo, Santa Cecília, 90035-003, Porto Alegre, RS, Brazil.
Felipe Lhywinskh GuellaDepartment of Biochemistry, Postgraduate Program in Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos, 2600 - Anexo, Santa Cecília, 90035-003, Porto Alegre, RS, Brazil.
Letícia Ferreira PettenuzzoDepartment of Biochemistry, Postgraduate Program in Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos, 2600 - Anexo, Santa Cecília, 90035-003, Porto Alegre, RS, Brazil.
Thiago DuartePostgraduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil.
Marta Maria Medeiros Frescura DuarteHealth Sciences Center, Lutheran University of Brazil (ULBRA) - Campus Santa Maria, Santa Maria, RS, Brazil.
Jean Pierre OsesPostgraduate Program in Health and Behavior, Health and Biological Sciences Center, Catholic University of Pelotas (UCPel), Pelotas, RS, Brazil.
Matilde AchavalDepartment of Compared Histophysiologies and Morphologic Science, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Diogo Onofre SouzaDepartment of Biochemistry, Postgraduate Program in Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos, 2600 - Anexo, Santa Cecília, 90035-003, Porto Alegre, RS, Brazil.
Universidade Federal do Rio Grande do Sul · BRUniversidade Católica de Pelotas · BRUniversidade Federal de Santa Maria · BRUniversidade Luterana do Brasil · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is the major cause of death and the most frequent cause of disability in the adult population worldwide. Guanosine plays an important neuroprotective role in several cerebral ischemic models and is involved in the modulation of oxidative responses and glutamatergic parameters. Because the excessive reactive oxygen species produced during an ischemic event can trigger an inflammatory response, the purpose of this study was to evaluate the hypothesis that guanosine is neuroprotective against focal cerebral ischemia, inhibits microglia/macrophages activation, and mediates an inflammatory response ameliorating the neural damage. Permanent focal cerebral ischemia was induced in adult rats, and guanosine was administered immediately, 1, 3, and 6 h after surgery. Twenty-four hours after ischemia, the asymmetry scores were evaluated by the cylinder test; neuronal damage was evaluated by Fluoro-Jade C (FJC) staining and propidium iodide (PI) incorporation; microglia and immune cells were evaluated by anti-Iba-1 antibody; and inflammatory parameters such as interleukins (IL): IL-1, IL-6, IL-10; tumor necrosis factors alpha (TNF-α); and interferon-gamma (INF-γ) were evaluated in the brain tissue and cerebrospinal fluid. The ischemic event increased the levels of Iba-1-positive cells and pro-inflammatory cytokines and decreased IL-10 levels (an anti-inflammatory cytokine) in the lesion periphery. The guanosine treatment attenuated the changes in these inflammatory parameters and also reduced the infarct volume, PI incorporation, and number of FJC-positive cells, improving the functional recovery. Thus, guanosine may have been a promising therapeutic agent for the treatment of ischemic brain injury by reduction of inflammatory process triggered in an ischemic event.

Indexed as

AnimalsAnti-Inflammatory AgentsBrainBrain IschemiaCytokinesDisease Models, AnimalGuanosineInflammationMaleMicrogliaNeuroprotective AgentsRats, WistarReactive Oxygen SpeciesAnti-Inflammatory AgentsCytokinesGuanosineNeuroprotective AgentsReactive Oxygen SpeciesCerebral ischemiaCytokinesGuanosineMicrogliaNeuroinflammationNeuroprotection

Identifiers

PMID25394382
OpenAlexW2165040339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.